Cargando…

Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles

Atopic dermatitis (AD) and psoriasis are the most common chronic inflammatory skin disorders, which importantly affect the quality of life of patients who suffer them. Among other causes, nitric oxide has been reported as part of the triggering factors in the pathogenesis of both conditions. Cyanoco...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillot, Antonio José, Jornet-Mollá, Enrique, Landsberg, Natalia, Milián-Guimerá, Carmen, Montesinos, M. Carmen, Garrigues, Teresa M., Melero, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003749/
https://www.ncbi.nlm.nih.gov/pubmed/33804652
http://dx.doi.org/10.3390/pharmaceutics13030418
_version_ 1783671762779635712
author Guillot, Antonio José
Jornet-Mollá, Enrique
Landsberg, Natalia
Milián-Guimerá, Carmen
Montesinos, M. Carmen
Garrigues, Teresa M.
Melero, Ana
author_facet Guillot, Antonio José
Jornet-Mollá, Enrique
Landsberg, Natalia
Milián-Guimerá, Carmen
Montesinos, M. Carmen
Garrigues, Teresa M.
Melero, Ana
author_sort Guillot, Antonio José
collection PubMed
description Atopic dermatitis (AD) and psoriasis are the most common chronic inflammatory skin disorders, which importantly affect the quality of life of patients who suffer them. Among other causes, nitric oxide has been reported as part of the triggering factors in the pathogenesis of both conditions. Cyanocobalamin (vitamin B(12)) has shown efficacy as a nitric oxide scavenger and some clinical trials have given positive outcomes in its use for treating skin pathologies. Passive skin diffusion is possible only for drugs with low molecular weights and intermediate lipophilicity. Unfortunately, the molecular weight and hydrophilicity of vitamin B(12) do not predict its effective diffusion through the skin. The aim of this work was to design new lipid vesicles to encapsulate the vitamin B(12) to enhance its skin penetration. Nine prototypes of vesicles were generated and characterized in terms of size, polydispersity, surface charge, drug encapsulation, flexibility, and stability with positive results. Additionally, their ability to release the drug content in a controlled manner was demonstrated. Finally, we found that these lipid vesicle formulations facilitated the penetration of cyanocobalamin to the deeper layers of the skin. The present work shows a promising system to effectively administer vitamin B(12) topically, which could be of interest in the treatment of skin diseases such as AD and psoriasis.
format Online
Article
Text
id pubmed-8003749
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80037492021-03-28 Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles Guillot, Antonio José Jornet-Mollá, Enrique Landsberg, Natalia Milián-Guimerá, Carmen Montesinos, M. Carmen Garrigues, Teresa M. Melero, Ana Pharmaceutics Article Atopic dermatitis (AD) and psoriasis are the most common chronic inflammatory skin disorders, which importantly affect the quality of life of patients who suffer them. Among other causes, nitric oxide has been reported as part of the triggering factors in the pathogenesis of both conditions. Cyanocobalamin (vitamin B(12)) has shown efficacy as a nitric oxide scavenger and some clinical trials have given positive outcomes in its use for treating skin pathologies. Passive skin diffusion is possible only for drugs with low molecular weights and intermediate lipophilicity. Unfortunately, the molecular weight and hydrophilicity of vitamin B(12) do not predict its effective diffusion through the skin. The aim of this work was to design new lipid vesicles to encapsulate the vitamin B(12) to enhance its skin penetration. Nine prototypes of vesicles were generated and characterized in terms of size, polydispersity, surface charge, drug encapsulation, flexibility, and stability with positive results. Additionally, their ability to release the drug content in a controlled manner was demonstrated. Finally, we found that these lipid vesicle formulations facilitated the penetration of cyanocobalamin to the deeper layers of the skin. The present work shows a promising system to effectively administer vitamin B(12) topically, which could be of interest in the treatment of skin diseases such as AD and psoriasis. MDPI 2021-03-20 /pmc/articles/PMC8003749/ /pubmed/33804652 http://dx.doi.org/10.3390/pharmaceutics13030418 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Guillot, Antonio José
Jornet-Mollá, Enrique
Landsberg, Natalia
Milián-Guimerá, Carmen
Montesinos, M. Carmen
Garrigues, Teresa M.
Melero, Ana
Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles
title Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles
title_full Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles
title_fullStr Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles
title_full_unstemmed Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles
title_short Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles
title_sort cyanocobalamin ultraflexible lipid vesicles: characterization and in vitro evaluation of drug-skin depth profiles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003749/
https://www.ncbi.nlm.nih.gov/pubmed/33804652
http://dx.doi.org/10.3390/pharmaceutics13030418
work_keys_str_mv AT guillotantoniojose cyanocobalaminultraflexiblelipidvesiclescharacterizationandinvitroevaluationofdrugskindepthprofiles
AT jornetmollaenrique cyanocobalaminultraflexiblelipidvesiclescharacterizationandinvitroevaluationofdrugskindepthprofiles
AT landsbergnatalia cyanocobalaminultraflexiblelipidvesiclescharacterizationandinvitroevaluationofdrugskindepthprofiles
AT milianguimeracarmen cyanocobalaminultraflexiblelipidvesiclescharacterizationandinvitroevaluationofdrugskindepthprofiles
AT montesinosmcarmen cyanocobalaminultraflexiblelipidvesiclescharacterizationandinvitroevaluationofdrugskindepthprofiles
AT garriguesteresam cyanocobalaminultraflexiblelipidvesiclescharacterizationandinvitroevaluationofdrugskindepthprofiles
AT meleroana cyanocobalaminultraflexiblelipidvesiclescharacterizationandinvitroevaluationofdrugskindepthprofiles